HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberta Ghidoni Selected Research

Dementia (Dementias)

1/2024Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.
7/2023CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia.
1/2022Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer's Disease and Dementia with Lewy Bodies.
1/2021Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants.
1/2021Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer's Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia.
1/2019Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer's disease in a Family with Late-onset Dementia.
1/2018Serum Copper is not Altered in Frontotemporal Lobar Degeneration.
1/2018Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.
1/2017TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
1/2016Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberta Ghidoni Research Topics

Disease

60Alzheimer Disease (Alzheimer's Disease)
01/2024 - 06/2003
32Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
11/2022 - 03/2009
24Frontotemporal Dementia (Semantic Dementia)
03/2024 - 05/2006
19Dementia (Dementias)
01/2024 - 12/2003
13Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 08/2005
13Cognitive Dysfunction
01/2017 - 02/2006
5Atrophy
01/2022 - 05/2009
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 08/2010
4Schizophrenia (Dementia Praecox)
07/2020 - 06/2011
3Disease Progression
01/2021 - 03/2015
3Inflammation (Inflammations)
07/2020 - 01/2012
2Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2016
2Amyloidosis
01/2022 - 06/2011
2Neoplasms (Cancer)
01/2016 - 10/2012
2Amyloid Plaque
01/2016 - 01/2011
2Wounds and Injuries (Trauma)
10/2012 - 01/2012
2Vascular Diseases (Vascular Disease)
07/2011 - 11/2005
1Ischemia
07/2023
1Brain Injuries (Brain Injury)
08/2022
1Cardiovascular Diseases (Cardiovascular Disease)
03/2022
1Genetic Risk Score
01/2021
1Autistic Disorder (Autism)
07/2020
1Epilepsy (Aura)
07/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2020
1Neurodevelopmental Disorders
07/2020
1Glucose Intolerance
07/2020
1Conversion Disorder (Astasia Abasia)
01/2020
1Parkinson Disease (Parkinson's Disease)
01/2019
1Hepatolenticular Degeneration (Wilson's Disease)
01/2018
1Brain Diseases (Brain Disorder)
01/2018
1Memory Disorders (Memory Loss)
01/2018
1Insulin Resistance
01/2018
1Prodromal Symptoms
01/2018

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
01/2023 - 11/2005
23ProgranulinsIBA
03/2024 - 03/2008
19Proteins (Proteins, Gene)FDA Link
03/2024 - 04/2007
9CopperIBA
03/2022 - 04/2010
8Amyloid (Amyloid Fibrils)IBA
01/2023 - 01/2011
7Apolipoproteins E (ApoE)IBA
07/2023 - 05/2009
7Peptides (Polypeptides)IBA
01/2021 - 01/2011
5Ceruloplasmin (Ferroxidase)IBA
01/2020 - 01/2011
5Cystatin CIBA
08/2011 - 06/2003
4Phosphotransferases (Kinase)IBA
10/2022 - 01/2011
4tau Proteins (tau Protein)IBA
03/2015 - 05/2006
4Presenilin-2IBA
04/2007 - 12/2003
4PresenilinsIBA
03/2007 - 03/2004
3Amyloid beta-PeptidesIBA
01/2023 - 01/2011
3IronIBA
07/2020 - 04/2014
3Ferritins (Ferritin)IBA
07/2020 - 04/2014
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2020 - 09/2013
3Presenilin-1IBA
01/2019 - 06/2006
3Cholinesterase Inhibitors (Anticholinesterases)IBA
06/2013 - 02/2010
3Protein Isoforms (Isoforms)IBA
12/2012 - 11/2005
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2011 - 03/2009
3Flavin-Adenine Dinucleotide (FAD)IBA
06/2006 - 03/2004
2ApolipoproteinsIBA
07/2023 - 02/2006
2MicroRNAs (MicroRNA)IBA
03/2022 - 10/2020
2Complement System Proteins (Complement)IBA
01/2022 - 05/2016
2GranulinsIBA
01/2022 - 10/2014
2Transferrin (beta 2 Transferrin)IBA
01/2020 - 04/2014
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 07/2009
2sortilinIBA
01/2018 - 01/2016
2Donepezil (Aricept)FDA LinkGeneric
01/2012 - 02/2010
2UbiquitinIBA
10/2010 - 01/2010
1Protein AggregatesIBA
01/2024
1ChemokinesIBA
07/2023
1Cathepsin DIBA
09/2022
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2022
1sharpinIBA
01/2021
1Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
01/2021
1CatecholaminesIBA
07/2020
1CobaltIBA
07/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2020
1ManganeseIBA
07/2020
1Methylphenidate (Ritalin)FDA LinkGeneric
07/2020
1SeleniumIBA
07/2020
1Trace Elements (Biometals)IBA
07/2020
1Antipsychotic Agents (Antipsychotics)IBA
07/2020
1ZincIBA
07/2020
1gamma-Aminobutyric Acid (GABA)IBA
01/2020
1PrionsIBA
01/2020
1Glial Fibrillary Acidic ProteinIBA
01/2020
1Genetic Markers (Genetic Marker)IBA
01/2020
1angiogeninIBA
04/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1Glutamic Acid (Glutamate)FDA Link
01/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2019
1HLA-DRB1 Chains (HLA DRB1)IBA
10/2018
1Untranslated RNA (Noncoding RNA)IBA
10/2018
1DipeptidesIBA
05/2018
1GhrelinIBA
01/2018
1Nicotinamide PhosphoribosyltransferaseIBA
01/2018
1Plasminogen Activator Inhibitor 1IBA
01/2018
1AdipokinesIBA
01/2018
1C-PeptideIBA
01/2018
1Insulin (Novolin)FDA Link
01/2018
1ResistinIBA
01/2018
1Glucagon-Like Peptides (Enteroglucagon)IBA
01/2018
1Glucagon (Glukagon)FDA Link
01/2018

Therapy/Procedure

3Therapeutics
01/2019 - 01/2016